Privia Health Insider Equity Sale: Analysis of Recent Executive Transactions
Recent regulatory filings have highlighted a notable equity transaction involving Shawn Morris, the former CEO and former Board member of Privia Health Group (NASDAQ: PRVA). According to SEC Form 4 disclosures, Morris executed 135,498 stock options and subsequently sold the resulting common shares, generating proceeds of approximately $3.57 million. Transaction Structure and Context The sale, […]










